The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Acinetobacter Infections Treatment Market Research Report 2023

Global Acinetobacter Infections Treatment Market Research Report 2023

Publishing Date : Jan, 2023

License Type :
 

Report Code : 1384858

No of Pages : 86

Ask Your Query

Synopsis
Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or “species” of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections.
Outbreaks of Acinetobacter infections typically occur in intensive care units and healthcare settings housing very ill patients. Acinetobacter infections rarely occur outside of healthcare settings.
Acinetobacter is often resistant to many commonly prescribed antibiotics. Decisions on treatment of infections with Acinetobacter should be made on a case-by-case basis by a healthcare provider. Acinetobacter infection typically occurs in ill patients and can either cause or contribute to death in these patients.
Highlights
The global Acinetobacter Infections Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In the American market, Major manufacturers include Entasis Therapeutics, Roche, Adenium Biotech, Vaxdyn, Hsiri Therapeutics, Aridis Pharmaceuticals, and Legochem Biosciences, Atterx Biotherapeutics, Achaogen, Peptilogics, Sealife Pharma, Shionogi, Techulon and Tetraphase Pharmaceuticals, among others. Entasis Therapeutics, Roche and Adenium Biotech are the top 3 players of Acinetobacter Infections Treatment, with about 66% market shares.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Acinetobacter Infections Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acinetobacter Infections Treatment.
The Acinetobacter Infections Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Acinetobacter Infections Treatment market comprehensively. Regional market sizes, concerning products by type, by pipeline, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acinetobacter Infections Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by pipeline, and by regions.
By Company

  • Entasis Therapeutics
  • Roche
  • Adenium Biotech
  • Vaxdyn
  • Hsiri Therapeutics
  • Aridis Pharmaceuticals
  • LegoChem Biosciences
  • Atterx Biotherapeutics
  • Achaogen
  • Peptilogics
  • Sealife PHARMA
  • Shionogi
  • Techulon
  • Tetraphase Pharmaceuticals

Segment by Type

  • Sulbactam
  • Carbapenems
  • Aminoglycosides
  • Polymyxins
  • Tetracyclines
  • Others

Segment by Pipeline

  • ETX2514
  • Nacubactam RG6080
  • Arenicin
  • VXD-001
  • Small Molecule Antibiotic
  • AR-401 mAB
  • LCB01-0371 (PO)
  • GN-4474
  • Antibacterial Antibody
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, pipeline, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acinetobacter Infections Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by pipeline, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acinetobacter Infections Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Sulbactam
1.2.3 Carbapenems
1.2.4 Aminoglycosides
1.2.5 Polymyxins
1.2.6 Tetracyclines
1.2.7 Others
1.3 Market by Pipeline
1.3.1 Global Acinetobacter Infections Treatment Market Growth by Pipeline: 2018 VS 2022 VS 2029
1.3.2 ETX2514
1.3.3 Nacubactam RG6080
1.3.4 Arenicin
1.3.5 VXD-001
1.3.6 Small Molecule Antibiotic
1.3.7 AR-401 mAB
1.3.8 LCB01-0371 (PO)
1.3.9 GN-4474
1.3.10 Antibacterial Antibody
1.3.11 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acinetobacter Infections Treatment Market Perspective (2018-2029)
2.2 Acinetobacter Infections Treatment Growth Trends by Region
2.2.1 Global Acinetobacter Infections Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Acinetobacter Infections Treatment Historic Market Size by Region (2018-2023)
2.2.3 Acinetobacter Infections Treatment Forecasted Market Size by Region (2024-2029)
2.3 Acinetobacter Infections Treatment Market Dynamics
2.3.1 Acinetobacter Infections Treatment Industry Trends
2.3.2 Acinetobacter Infections Treatment Market Drivers
2.3.3 Acinetobacter Infections Treatment Market Challenges
2.3.4 Acinetobacter Infections Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acinetobacter Infections Treatment Players by Revenue
3.1.1 Global Top Acinetobacter Infections Treatment Players by Revenue (2018-2023)
3.1.2 Global Acinetobacter Infections Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Acinetobacter Infections Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acinetobacter Infections Treatment Revenue
3.4 Global Acinetobacter Infections Treatment Market Concentration Ratio
3.4.1 Global Acinetobacter Infections Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acinetobacter Infections Treatment Revenue in 2022
3.5 Acinetobacter Infections Treatment Key Players Head office and Area Served
3.6 Key Players Acinetobacter Infections Treatment Product Solution and Service
3.7 Date of Enter into Acinetobacter Infections Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acinetobacter Infections Treatment Breakdown Data by Type
4.1 Global Acinetobacter Infections Treatment Historic Market Size by Type (2018-2023)
4.2 Global Acinetobacter Infections Treatment Forecasted Market Size by Type (2024-2029)
5 Acinetobacter Infections Treatment Breakdown Data by Pipeline
5.1 Global Acinetobacter Infections Treatment Historic Market Size by Pipeline (2018-2023)
5.2 Global Acinetobacter Infections Treatment Forecasted Market Size by Pipeline (2024-2029)
6 North America
6.1 North America Acinetobacter Infections Treatment Market Size (2018-2029)
6.2 North America Acinetobacter Infections Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Acinetobacter Infections Treatment Market Size by Country (2018-2023)
6.4 North America Acinetobacter Infections Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acinetobacter Infections Treatment Market Size (2018-2029)
7.2 Europe Acinetobacter Infections Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Acinetobacter Infections Treatment Market Size by Country (2018-2023)
7.4 Europe Acinetobacter Infections Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acinetobacter Infections Treatment Market Size (2018-2029)
8.2 Asia-Pacific Acinetobacter Infections Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Acinetobacter Infections Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Acinetobacter Infections Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acinetobacter Infections Treatment Market Size (2018-2029)
9.2 Latin America Acinetobacter Infections Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Acinetobacter Infections Treatment Market Size by Country (2018-2023)
9.4 Latin America Acinetobacter Infections Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acinetobacter Infections Treatment Market Size (2018-2029)
10.2 Middle East & Africa Acinetobacter Infections Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Entasis Therapeutics
11.1.1 Entasis Therapeutics Company Detail
11.1.2 Entasis Therapeutics Business Overview
11.1.3 Entasis Therapeutics Acinetobacter Infections Treatment Introduction
11.1.4 Entasis Therapeutics Revenue in Acinetobacter Infections Treatment Business (2018-2023)
11.1.5 Entasis Therapeutics Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Acinetobacter Infections Treatment Introduction
11.2.4 Roche Revenue in Acinetobacter Infections Treatment Business (2018-2023)
11.2.5 Roche Recent Development
11.3 Adenium Biotech
11.3.1 Adenium Biotech Company Detail
11.3.2 Adenium Biotech Business Overview
11.3.3 Adenium Biotech Acinetobacter Infections Treatment Introduction
11.3.4 Adenium Biotech Revenue in Acinetobacter Infections Treatment Business (2018-2023)
11.3.5 Adenium Biotech Recent Development
11.4 Vaxdyn
11.4.1 Vaxdyn Company Detail
11.4.2 Vaxdyn Business Overview
11.4.3 Vaxdyn Acinetobacter Infections Treatment Introduction
11.4.4 Vaxdyn Revenue in Acinetobacter Infections Treatment Business (2018-2023)
11.4.5 Vaxdyn Recent Development
11.5 Hsiri Therapeutics
11.5.1 Hsiri Therapeutics Company Detail
11.5.2 Hsiri Therapeutics Business Overview
11.5.3 Hsiri Therapeutics Acinetobacter Infections Treatment Introduction
11.5.4 Hsiri Therapeutics Revenue in Acinetobacter Infections Treatment Business (2018-2023)
11.5.5 Hsiri Therapeutics Recent Development
11.6 Aridis Pharmaceuticals
11.6.1 Aridis Pharmaceuticals Company Detail
11.6.2 Aridis Pharmaceuticals Business Overview
11.6.3 Aridis Pharmaceuticals Acinetobacter Infections Treatment Introduction
11.6.4 Aridis Pharmaceuticals Revenue in Acinetobacter Infections Treatment Business (2018-2023)
11.6.5 Aridis Pharmaceuticals Recent Development
11.7 LegoChem Biosciences
11.7.1 LegoChem Biosciences Company Detail
11.7.2 LegoChem Biosciences Business Overview
11.7.3 LegoChem Biosciences Acinetobacter Infections Treatment Introduction
11.7.4 LegoChem Biosciences Revenue in Acinetobacter Infections Treatment Business (2018-2023)
11.7.5 LegoChem Biosciences Recent Development
11.8 Atterx Biotherapeutics
11.8.1 Atterx Biotherapeutics Company Detail
11.8.2 Atterx Biotherapeutics Business Overview
11.8.3 Atterx Biotherapeutics Acinetobacter Infections Treatment Introduction
11.8.4 Atterx Biotherapeutics Revenue in Acinetobacter Infections Treatment Business (2018-2023)
11.8.5 Atterx Biotherapeutics Recent Development
11.9 Achaogen
11.9.1 Achaogen Company Detail
11.9.2 Achaogen Business Overview
11.9.3 Achaogen Acinetobacter Infections Treatment Introduction
11.9.4 Achaogen Revenue in Acinetobacter Infections Treatment Business (2018-2023)
11.9.5 Achaogen Recent Development
11.10 Peptilogics
11.10.1 Peptilogics Company Detail
11.10.2 Peptilogics Business Overview
11.10.3 Peptilogics Acinetobacter Infections Treatment Introduction
11.10.4 Peptilogics Revenue in Acinetobacter Infections Treatment Business (2018-2023)
11.10.5 Peptilogics Recent Development
11.11 Sealife PHARMA
11.11.1 Sealife PHARMA Company Detail
11.11.2 Sealife PHARMA Business Overview
11.11.3 Sealife PHARMA Acinetobacter Infections Treatment Introduction
11.11.4 Sealife PHARMA Revenue in Acinetobacter Infections Treatment Business (2018-2023)
11.11.5 Sealife PHARMA Recent Development
11.12 Shionogi
11.12.1 Shionogi Company Detail
11.12.2 Shionogi Business Overview
11.12.3 Shionogi Acinetobacter Infections Treatment Introduction
11.12.4 Shionogi Revenue in Acinetobacter Infections Treatment Business (2018-2023)
11.12.5 Shionogi Recent Development
11.13 Techulon
11.13.1 Techulon Company Detail
11.13.2 Techulon Business Overview
11.13.3 Techulon Acinetobacter Infections Treatment Introduction
11.13.4 Techulon Revenue in Acinetobacter Infections Treatment Business (2018-2023)
11.13.5 Techulon Recent Development
11.14 Tetraphase Pharmaceuticals
11.14.1 Tetraphase Pharmaceuticals Company Detail
11.14.2 Tetraphase Pharmaceuticals Business Overview
11.14.3 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Introduction
11.14.4 Tetraphase Pharmaceuticals Revenue in Acinetobacter Infections Treatment Business (2018-2023)
11.14.5 Tetraphase Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Acinetobacter Infections Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Sulbactam
Table 3. Key Players of Carbapenems
Table 4. Key Players of Aminoglycosides
Table 5. Key Players of Polymyxins
Table 6. Key Players of Tetracyclines
Table 7. Key Players of Others
Table 8. Global Acinetobacter Infections Treatment Market Size Growth by Pipeline (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Acinetobacter Infections Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Acinetobacter Infections Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Acinetobacter Infections Treatment Market Share by Region (2018-2023)
Table 12. Global Acinetobacter Infections Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global Acinetobacter Infections Treatment Market Share by Region (2024-2029)
Table 14. Acinetobacter Infections Treatment Market Trends
Table 15. Acinetobacter Infections Treatment Market Drivers
Table 16. Acinetobacter Infections Treatment Market Challenges
Table 17. Acinetobacter Infections Treatment Market Restraints
Table 18. Global Acinetobacter Infections Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Acinetobacter Infections Treatment Market Share by Players (2018-2023)
Table 20. Global Top Acinetobacter Infections Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acinetobacter Infections Treatment as of 2022)
Table 21. Ranking of Global Top Acinetobacter Infections Treatment Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Acinetobacter Infections Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Acinetobacter Infections Treatment Product Solution and Service
Table 25. Date of Enter into Acinetobacter Infections Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Acinetobacter Infections Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Acinetobacter Infections Treatment Revenue Market Share by Type (2018-2023)
Table 29. Global Acinetobacter Infections Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global Acinetobacter Infections Treatment Revenue Market Share by Type (2024-2029)
Table 31. Global Acinetobacter Infections Treatment Market Size by Pipeline (2018-2023) & (US$ Million)
Table 32. Global Acinetobacter Infections Treatment Revenue Market Share by Pipeline (2018-2023)
Table 33. Global Acinetobacter Infections Treatment Forecasted Market Size by Pipeline (2024-2029) & (US$ Million)
Table 34. Global Acinetobacter Infections Treatment Revenue Market Share by Pipeline (2024-2029)
Table 35. North America Acinetobacter Infections Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Acinetobacter Infections Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Acinetobacter Infections Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Acinetobacter Infections Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. Europe Acinetobacter Infections Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Acinetobacter Infections Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 41. Asia-Pacific Acinetobacter Infections Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Asia-Pacific Acinetobacter Infections Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Acinetobacter Infections Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 44. Latin America Acinetobacter Infections Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Latin America Acinetobacter Infections Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Acinetobacter Infections Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. Middle East & Africa Acinetobacter Infections Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 50. Entasis Therapeutics Company Detail
Table 51. Entasis Therapeutics Business Overview
Table 52. Entasis Therapeutics Acinetobacter Infections Treatment Product
Table 53. Entasis Therapeutics Revenue in Acinetobacter Infections Treatment Business (2018-2023) & (US$ Million)
Table 54. Entasis Therapeutics Recent Development
Table 55. Roche Company Detail
Table 56. Roche Business Overview
Table 57. Roche Acinetobacter Infections Treatment Product
Table 58. Roche Revenue in Acinetobacter Infections Treatment Business (2018-2023) & (US$ Million)
Table 59. Roche Recent Development
Table 60. Adenium Biotech Company Detail
Table 61. Adenium Biotech Business Overview
Table 62. Adenium Biotech Acinetobacter Infections Treatment Product
Table 63. Adenium Biotech Revenue in Acinetobacter Infections Treatment Business (2018-2023) & (US$ Million)
Table 64. Adenium Biotech Recent Development
Table 65. Vaxdyn Company Detail
Table 66. Vaxdyn Business Overview
Table 67. Vaxdyn Acinetobacter Infections Treatment Product
Table 68. Vaxdyn Revenue in Acinetobacter Infections Treatment Business (2018-2023) & (US$ Million)
Table 69. Vaxdyn Recent Development
Table 70. Hsiri Therapeutics Company Detail
Table 71. Hsiri Therapeutics Business Overview
Table 72. Hsiri Therapeutics Acinetobacter Infections Treatment Product
Table 73. Hsiri Therapeutics Revenue in Acinetobacter Infections Treatment Business (2018-2023) & (US$ Million)
Table 74. Hsiri Therapeutics Recent Development
Table 75. Aridis Pharmaceuticals Company Detail
Table 76. Aridis Pharmaceuticals Business Overview
Table 77. Aridis Pharmaceuticals Acinetobacter Infections Treatment Product
Table 78. Aridis Pharmaceuticals Revenue in Acinetobacter Infections Treatment Business (2018-2023) & (US$ Million)
Table 79. Aridis Pharmaceuticals Recent Development
Table 80. LegoChem Biosciences Company Detail
Table 81. LegoChem Biosciences Business Overview
Table 82. LegoChem Biosciences Acinetobacter Infections Treatment Product
Table 83. LegoChem Biosciences Revenue in Acinetobacter Infections Treatment Business (2018-2023) & (US$ Million)
Table 84. LegoChem Biosciences Recent Development
Table 85. Atterx Biotherapeutics Company Detail
Table 86. Atterx Biotherapeutics Business Overview
Table 87. Atterx Biotherapeutics Acinetobacter Infections Treatment Product
Table 88. Atterx Biotherapeutics Revenue in Acinetobacter Infections Treatment Business (2018-2023) & (US$ Million)
Table 89. Atterx Biotherapeutics Recent Development
Table 90. Achaogen Company Detail
Table 91. Achaogen Business Overview
Table 92. Achaogen Acinetobacter Infections Treatment Product
Table 93. Achaogen Revenue in Acinetobacter Infections Treatment Business (2018-2023) & (US$ Million)
Table 94. Achaogen Recent Development
Table 95. Peptilogics Company Detail
Table 96. Peptilogics Business Overview
Table 97. Peptilogics Acinetobacter Infections Treatment Product
Table 98. Peptilogics Revenue in Acinetobacter Infections Treatment Business (2018-2023) & (US$ Million)
Table 99. Peptilogics Recent Development
Table 100. Sealife PHARMA Company Detail
Table 101. Sealife PHARMA Business Overview
Table 102. Sealife PHARMA Acinetobacter Infections Treatment Product
Table 103. Sealife PHARMA Revenue in Acinetobacter Infections Treatment Business (2018-2023) & (US$ Million)
Table 104. Sealife PHARMA Recent Development
Table 105. Shionogi Company Detail
Table 106. Shionogi Business Overview
Table 107. Shionogi Acinetobacter Infections Treatment Product
Table 108. Shionogi Revenue in Acinetobacter Infections Treatment Business (2018-2023) & (US$ Million)
Table 109. Shionogi Recent Development
Table 110. Techulon Company Detail
Table 111. Techulon Business Overview
Table 112. Techulon Acinetobacter Infections Treatment Product
Table 113. Techulon Revenue in Acinetobacter Infections Treatment Business (2018-2023) & (US$ Million)
Table 114. Techulon Recent Development
Table 115. Tetraphase Pharmaceuticals Company Detail
Table 116. Tetraphase Pharmaceuticals Business Overview
Table 117. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Product
Table 118. Tetraphase Pharmaceuticals Revenue in Acinetobacter Infections Treatment Business (2018-2023) & (US$ Million)
Table 119. Tetraphase Pharmaceuticals Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acinetobacter Infections Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Acinetobacter Infections Treatment Market Share by Type: 2022 VS 2029
Figure 3. Sulbactam Features
Figure 4. Carbapenems Features
Figure 5. Aminoglycosides Features
Figure 6. Polymyxins Features
Figure 7. Tetracyclines Features
Figure 8. Others Features
Figure 9. Global Acinetobacter Infections Treatment Market Size Comparison by Pipeline (2023-2029) & (US$ Million)
Figure 10. Global Acinetobacter Infections Treatment Market Share by Pipeline: 2022 VS 2029
Figure 11. ETX2514 Case Studies
Figure 12. Nacubactam RG6080 Case Studies
Figure 13. Arenicin Case Studies
Figure 14. VXD-001 Case Studies
Figure 15. Small Molecule Antibiotic Case Studies
Figure 16. AR-401 mAB Case Studies
Figure 17. LCB01-0371 (PO) Case Studies
Figure 18. GN-4474 Case Studies
Figure 19. Antibacterial Antibody Case Studies
Figure 20. Others Case Studies
Figure 21. Acinetobacter Infections Treatment Report Years Considered
Figure 22. Global Acinetobacter Infections Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 23. Global Acinetobacter Infections Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 24. Global Acinetobacter Infections Treatment Market Share by Region: 2022 VS 2029
Figure 25. Global Acinetobacter Infections Treatment Market Share by Players in 2022
Figure 26. Global Top Acinetobacter Infections Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acinetobacter Infections Treatment as of 2022)
Figure 27. The Top 10 and 5 Players Market Share by Acinetobacter Infections Treatment Revenue in 2022
Figure 28. North America Acinetobacter Infections Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. North America Acinetobacter Infections Treatment Market Share by Country (2018-2029)
Figure 30. United States Acinetobacter Infections Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Canada Acinetobacter Infections Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Europe Acinetobacter Infections Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Europe Acinetobacter Infections Treatment Market Share by Country (2018-2029)
Figure 34. Germany Acinetobacter Infections Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. France Acinetobacter Infections Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. U.K. Acinetobacter Infections Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Italy Acinetobacter Infections Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Russia Acinetobacter Infections Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Nordic Countries Acinetobacter Infections Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Asia-Pacific Acinetobacter Infections Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Asia-Pacific Acinetobacter Infections Treatment Market Share by Region (2018-2029)
Figure 42. China Acinetobacter Infections Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Japan Acinetobacter Infections Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea Acinetobacter Infections Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Acinetobacter Infections Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Acinetobacter Infections Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Acinetobacter Infections Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Latin America Acinetobacter Infections Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Latin America Acinetobacter Infections Treatment Market Share by Country (2018-2029)
Figure 50. Mexico Acinetobacter Infections Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Brazil Acinetobacter Infections Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Middle East & Africa Acinetobacter Infections Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Middle East & Africa Acinetobacter Infections Treatment Market Share by Country (2018-2029)
Figure 54. Turkey Acinetobacter Infections Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Acinetobacter Infections Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Entasis Therapeutics Revenue Growth Rate in Acinetobacter Infections Treatment Business (2018-2023)
Figure 57. Roche Revenue Growth Rate in Acinetobacter Infections Treatment Business (2018-2023)
Figure 58. Adenium Biotech Revenue Growth Rate in Acinetobacter Infections Treatment Business (2018-2023)
Figure 59. Vaxdyn Revenue Growth Rate in Acinetobacter Infections Treatment Business (2018-2023)
Figure 60. Hsiri Therapeutics Revenue Growth Rate in Acinetobacter Infections Treatment Business (2018-2023)
Figure 61. Aridis Pharmaceuticals Revenue Growth Rate in Acinetobacter Infections Treatment Business (2018-2023)
Figure 62. LegoChem Biosciences Revenue Growth Rate in Acinetobacter Infections Treatment Business (2018-2023)
Figure 63. Atterx Biotherapeutics Revenue Growth Rate in Acinetobacter Infections Treatment Business (2018-2023)
Figure 64. Achaogen Revenue Growth Rate in Acinetobacter Infections Treatment Business (2018-2023)
Figure 65. Peptilogics Revenue Growth Rate in Acinetobacter Infections Treatment Business (2018-2023)
Figure 66. Sealife PHARMA Revenue Growth Rate in Acinetobacter Infections Treatment Business (2018-2023)
Figure 67. Shionogi Revenue Growth Rate in Acinetobacter Infections Treatment Business (2018-2023)
Figure 68. Techulon Revenue Growth Rate in Acinetobacter Infections Treatment Business (2018-2023)
Figure 69. Tetraphase Pharmaceuticals Revenue Growth Rate in Acinetobacter Infections Treatment Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock